Trials / Completed
CompletedNCT00788710
A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)
A Double-Blind, Placebo-Controlled, Multicenter Trial to Study the Efficacy and Tolerability of MK0663/Etoricoxib in the Treatment of Pain After Abdominal Hysterectomy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 430 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of etoricoxib compared to placebo in the treatment of postoperative pain associated with total abdominal hysterectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | etoricoxib (MK0663) 120 mg | 120 mg of etoricoxib (MK0663) for a total of 5 days |
| DRUG | Comparator: Placebo | Placebo tablets once daily on Days 1-5. Total treatment is 5 days. |
| DRUG | etoricoxib (MK0663) 90 mg | 90 mg of etoricoxib (MK0663) for a total of 5 days |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2008-11-11
- Last updated
- 2022-02-09
- Results posted
- 2011-07-22
Source: ClinicalTrials.gov record NCT00788710. Inclusion in this directory is not an endorsement.